ifosfamide has been researched along with Heart Failure in 4 studies
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To explore the effect of high-dose ifosfamide in first-line treatment for patients < or = 40 years of age with nonmetastatic osteosarcoma of the extremity." | 9.11 | Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. ( Alvegard, TA; Bacci, G; Bernini, G; Bertoni, F; Böhling, T; Brosjö, O; Capanna, R; Comandone, A; Del Prever, AB; Ferrari, S; Longhi, A; Mercuri, M; Müller, C; Picci, P; Ruggieri, P; Saeter, G; Smeland, S; Tienghi, A; Wiebe, T, 2005) |
| "To explore the effect of high-dose ifosfamide in first-line treatment for patients < or = 40 years of age with nonmetastatic osteosarcoma of the extremity." | 5.11 | Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. ( Alvegard, TA; Bacci, G; Bernini, G; Bertoni, F; Böhling, T; Brosjö, O; Capanna, R; Comandone, A; Del Prever, AB; Ferrari, S; Longhi, A; Mercuri, M; Müller, C; Picci, P; Ruggieri, P; Saeter, G; Smeland, S; Tienghi, A; Wiebe, T, 2005) |
| "High-dose ifosfamide is associated with severe but usually reversible myocardial depression and malignant arrhythmias." | 5.07 | High-dose ifosfamide is associated with severe, reversible cardiac dysfunction. ( Bryant, G; Cunnion, RE; Ognibene, FP; Parker, MM; Quezado, ZM; Reda, D; Wilson, WH, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferrari, S | 1 |
| Smeland, S | 1 |
| Mercuri, M | 1 |
| Bertoni, F | 1 |
| Longhi, A | 1 |
| Ruggieri, P | 1 |
| Alvegard, TA | 1 |
| Picci, P | 1 |
| Capanna, R | 1 |
| Bernini, G | 1 |
| Müller, C | 1 |
| Tienghi, A | 1 |
| Wiebe, T | 1 |
| Comandone, A | 1 |
| Böhling, T | 1 |
| Del Prever, AB | 1 |
| Brosjö, O | 1 |
| Bacci, G | 1 |
| Saeter, G | 1 |
| Quezado, ZM | 1 |
| Wilson, WH | 1 |
| Cunnion, RE | 1 |
| Parker, MM | 1 |
| Reda, D | 1 |
| Bryant, G | 1 |
| Ognibene, FP | 1 |
| Wexler, LH | 1 |
| DeLaney, TF | 1 |
| Tsokos, M | 1 |
| Avila, N | 1 |
| Steinberg, SM | 1 |
| Weaver-McClure, L | 1 |
| Jacobson, J | 1 |
| Jarosinski, P | 1 |
| Hijazi, YM | 1 |
| Balis, FM | 1 |
| Horowitz, ME | 1 |
| Franzen, D | 1 |
| Pöhler, E | 1 |
| Hilger, HH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Multicenter Observational Study on the Treatment of Patients With Localized Osteosarcoma[NCT04890067] | 120 participants (Anticipated) | Observational | 2021-07-30 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for ifosfamide and Heart Failure
| Article | Year |
|---|---|
Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre | 2005 |
High-dose ifosfamide is associated with severe, reversible cardiac dysfunction.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Bone | 1993 |
Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosp | 1996 |
1 other study available for ifosfamide and Heart Failure
| Article | Year |
|---|---|
[Pneumo- and cardiotoxic side effects following combination chemotherapy with epirubicin and ifosfamide].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intraductal, Non | 1990 |